Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of ZOSTAVAX in Subjects ≥ 60 Years
NCT00550745Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2007
- Primary completion
- Jan 2009
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 4 trial of varicella virus vaccine live in herpes zoster (HZ), sponsored by Merck & Co.. Started Sep 2007; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00550745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550745.